ADAM17 and breast cancer: Moreover, a previous study in breast cancer model reported that ADAM17 was upregulated by severe hypoxia and xenografts that had been treated with bevacizumab showed significantly higher ADAM17 mRNA levels and enzyme activity compared with control tumors [58].